Cargando…

Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease

Inflammatory bowel disease (IBD) such as Crohn’s disease and ulcerative colitis is a chronic autoimmune disease affecting nearly five million people worldwide. Among all drug delivery system, oral administration is the most preferable route for colon-specific targeting and the treatment of IBD. Here...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Hongzhi, Fang, Dong, Chen, Jing, Sun, Yuan, Kang, Chen, Di, Liuqing, Li, Junsong, Chen, Zhipeng, Chen, Jun, Gao, Yahan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240970/ https://www.ncbi.nlm.nih.gov/pubmed/28156160 http://dx.doi.org/10.1080/10717544.2016.1245367

Ejemplares similares

Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate
por: Qiao, Hongzhi, et al.
Publicado: (2017)

Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles
por: Xun, Zhe, et al.
Publicado: (2018)

Oral Administration of Therapeutic Enzyme Capsule for the Management of Inflammatory Bowel Disease
por: Liang, Xiao, et al.
Publicado: (2022)

Insight into the Relationship between Oral Microbiota and the Inflammatory Bowel Disease
por: Han, Yimin, et al.
Publicado: (2022)

Optimization of the Preparation Conditions of Borneol-Modified Ginkgolide Liposomes by Response Surface Methodology and Study of Their Blood Brain Barrier Permeability
por: Lv, Zhiyang, et al.
Publicado: (2018)

Contact Lenses Delivering Nitric Oxide under Daylight for Reduction of Bacterial Contamination
por: Seggio, Mimimorena, et al.
Publicado: (2019)

Bioelectrical Stimulation for the Reduction of Inflammation in Inflammatory Bowel Disease
por: Marshall, Ryan, et al.
Publicado: (2015)

Oral zero-valent-molybdenum nanodots for inflammatory bowel disease therapy
por: Zhang, Chen, et al.
Publicado: (2022)

Bacterial Species Associated With Human Inflammatory Bowel Disease and Their Pathogenic Mechanisms
por: Zhang, Li, et al.
Publicado: (2022)

Assessing Oral Medication Adherence and Identifying Predictors of Low Adherence in Chinese Inflammatory Bowel Disease Patients
por: Hu, Wen, et al.
Publicado: (2020)

The Technical Quality of Delivered Care for People with Inflammatory Bowel Disease in Tabriz Gastroenterology Clinics
por: Tabrizi, Jafar Sadegh, et al.
Publicado: (2015)

The Immune Strategy and Stress Response of the Mediterranean Species of the Bemisia tabaci Complex to an Orally Delivered Bacterial Pathogen
por: Zhang, Chang-Rong, et al.
Publicado: (2014)

Effect of Physician-Delivered Patient Education on the Quality of Bowel Preparation for Screening Colonoscopy
por: Shieh, Tze-Yu, et al.
Publicado: (2013)

Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model
por: Dianzani, Chiara, et al.
Publicado: (2017)

Metabolomics facilitate the personalized management in inflammatory bowel disease
por: Chen, Rirong, et al.
Publicado: (2021)

Potential synaptic plasticity‐based Shenzhiling oral liquid for a SAD Mouse Model
por: Wang, Yahan, et al.
Publicado: (2019)

The regulatory role of alternative splicing in inflammatory bowel disease
por: Zhou, Jianli, et al.
Publicado: (2023)

Lactobacillus murinus Improved the Bioavailability of Orally Administered Glycyrrhizic Acid in Rats
por: Yuan, Tianjie, et al.
Publicado: (2020)

Therapeutic effects of lentinan on inflammatory bowel disease and colitis‐associated cancer
por: Liu, Yanrong, et al.
Publicado: (2018)

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery
por: Zhou, Jun, et al.
Publicado: (2022)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment
por: Zhang, Wunan, et al.
Publicado: (2021)

Microenvironmental Factors that Shape Bacterial Metabolites in Inflammatory Bowel Disease
por: Lopez, Lacey R., et al.
Publicado: (2022)

Preventable burden of head and neck cancer attributable to tobacco and alcohol between 1990 and 2039 in China
por: Song, Cheng, et al.
Publicado: (2023)

New insights into bacterial mechanisms and potential intestinal epithelial cell therapeutic targets of inflammatory bowel disease
por: Liang, Bing, et al.
Publicado: (2022)

Study on myelin injury of AD mice treated with Shenzhiling oral liquid in the PI3K/Akt–mTOR pathway
por: Wang, Yahan, et al.
Publicado: (2020)

A Comparative Pharmacokinetic Study by UHPLC-MS/MS of Main Active Compounds after Oral Administration of Zushima-Gancao Extract in Normal and Adjuvant-Induced Arthritis Rats
por: Shan, Jinjun, et al.
Publicado: (2018)

Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease
por: Wang, Huiling, et al.
Publicado: (2016)

Surmounting tumor resistance to metallodrugs by co-loading a metal complex and siRNA in nanoparticles
por: Qiao, Hongzhi, et al.
Publicado: (2021)

Medication adherence in inflammatory bowel disease
por: Chan, Webber, et al.
Publicado: (2017)

Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease
por: Hu, Shurong, et al.
Publicado: (2021)

An oral cholera vaccine in the prevention and/or treatment of inflammatory bowel disease
por: Meunier, Marine, et al.
Publicado: (2023)

The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases
por: Sanagapalli, Santosh, et al.
Publicado: (2018)

Lipoprotein-biomimetic nanostructure enables tumor-targeted penetration delivery for enhanced photo-gene therapy towards glioma
por: Wang, Ruoning, et al.
Publicado: (2021)

Altered gut bacterial and metabolic signatures and their interaction in inflammatory bowel disease
por: Liang, Guangcai
Publicado: (2021)

Appendiceal diverticulitis and inflammatory bowel disease
por: Hui, Martha Lok-Yung, et al.
Publicado: (2023)

Enterohepatic Helicobacter Species as a Potential Causative Factor in Inflammatory Bowel Disease: A Meta-Analysis
por: Yu, Qiao, et al.
Publicado: (2015)

The Association between Periodontitis and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
por: Zhang, Yangheng, et al.
Publicado: (2021)

Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier
por: Mao, Aipeng, et al.
Publicado: (2023)

Anti-Inflammatory and Anti-Bacterial Potential of Mulberry Leaf Extract on Oral Microorganisms
por: Kim, Dokyeong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nsuecej8kt8g2kb3rnfjc190qf